Kantum Pharma, Inc. — Form D
Kantum Pharma, Inc. of CONCORD, NH, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-13. The offering totals $3.5M, of which $3.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-07-13
- Form: D
- Accession: 0001747673-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $3.5M
- Investors: 44
- Date of first sale: 2021-06-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-405951
Issuer
- Name: Kantum Pharma, Inc.
- CIK: 0001747673
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 75 SOUTH MAIN STREET, CONCORD, NH, 03301
- Phone: 603-876-6200
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Glenn Batchelder | Director | Corcord, NH |
| Sylvie Breton | Director | Concord, NH |
| Jean-Francois Carbonneau | Director | Concord, NH |
| Thomas Needham | Director | Cary, NC |
| Cory Wallenstein | Director | Concord, NH |
| Glenn Batchelder | Executive Officer | Corcord, NH |
| Andrea Franz | Executive Officer | Concord, NH |
| Jean-Francois Carbonneau | Executive Officer | Concord, NH |
| Rachel Liberman | Director | Concord, NH |
| Leileata Russo | Director | Concord, NH |
Other filings by this issuer (2)
More